Back to search
FDAFDA · Food and drugs·Recall number D-0074-2027

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60

Published November 4, 2026 · Recall initiated: October 9, 2026

Summary

FDA records drug Class II recall D-0074-2027, published November 4, 2026 and initiated October 9, 2026. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: 1296 bottles; Lot: Lot #: 13250135, Exp. Date 11/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified

What to do

Voluntary: Firm initiated

Get an email if ABIRATERONE ACETATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ABIRATERONE ACETATE
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
Nationwide within the United States
UPC
0368462882603
Lot
Lot #: 13250135, Exp. Date 11/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60 recalled?

Yes. FDA published recall D-0074-2027 on November 4, 2026. Reported hazard: Labeling: Not Elsewhere Classified

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ABIRATERONE ACETATE. UPC: 0368462882603.